Topography and Temporal Evolution of Hypoxic Viable Tissue Identified by 18F-Fluoromisonidazole Positron Emission Tomography in Humans After Ischemic Stroke

Background and Purpose— We sought to characterize the spatial and temporal evolution of human cerebral infarction. Using a novel method of quantitatively mapping the distribution of hypoxic viable tissue identified by 18F-fluoromisonidazole (18F-FMISO) PET relative to the final infarct, we determined its evolution and spatial topography in human stroke. Methods— Patients with acute middle cerebral artery territory stroke were imaged with 18F-FMISO PET (n=19; <6 hours, 4; 6 to 16 hours, 4; 16 to 24 hours, 5; 24 to 48 hours, 6). The hypoxic volume (HV) comprised voxels with significant (P <0.05; >1 mL) uptake on statistical parametric mapping compared with 15 age-matched controls. Central, peripheral, and external zones of the corresponding infarct on the anatomically coregistered delayed CT were defined according to voxel distance from the infarct center and subdivided into 24 regions by coronal, sagittal, and axial planes. Maps (“penumbragrams”) displaying the percentage of HV in each region were generated for each time epoch. Results— Higher HV was observed in the central region of the infarct in patients studied within 6 hours of onset (analysis of covariance [ANCOVA]; P <0.05) compared with those studied later, in whom the HV was mainly in the periphery or external to the infarct. HV was maximal in the superior, mesial, and posterior regions of the infarct (ANCOVA; P <0.05). Conclusions— These observations suggest that infarct expansion occurs at the expense of hypoxic tissue from the center to the periphery of the ischemic region in humans, similar to that seen in experimental animal models. These findings have important pathophysiological and therapeutic implications.

[1]  S M Davis,et al.  Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. , 1999, Stroke.

[2]  Fausto Viader,et al.  Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra , 1996, Annals of neurology.

[3]  S. Jasko,et al.  Therapy , 1881, The American journal of dental science.

[4]  A. Algra,et al.  Reproducibility of Measurements of Cerebral Infarct Volume on CT Scans , 2001, Stroke.

[5]  M. Lythgoe,et al.  The relationship between magnetic resonance diffusion imaging and autoradiographic markers of cerebral blood flow and hypoxia in an animal stroke model , 1999, Magnetic resonance in medicine.

[6]  M Fisher,et al.  Characterizing the target of acute stroke therapy. , 1997, Stroke.

[7]  D. Abbott,et al.  Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole , 1998, Neurology.

[8]  N C Huang,et al.  The evolution of acute stroke recorded by multimodal magnetic resonance imaging. , 1993, Magnetic resonance imaging.

[9]  Ninds,et al.  Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography , 2000, Stroke.

[10]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[11]  K Wienhard,et al.  Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[13]  David C. Reutens,et al.  Statistical Parametric Mapping of Hypoxic Tissue Identified by [18F]Fluoromisonidazole and Positron Emission Tomography Following Acute Ischemic Stroke , 2002, NeuroImage.

[14]  G. Schlaug,et al.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.

[15]  W. Heiss,et al.  Dynamic Penumbra Demonstrated by Sequential Multitracer PET after Middle Cerebral Artery Occlusion in Cats , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  J. Baron,et al.  Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume. , 1997, Stroke.

[17]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[18]  Jean-Claude Baron,et al.  Mapping the Ischaemic Penumbra with PET: Implications for Acute Stroke Treatment , 1999, Cerebrovascular Diseases.

[19]  V Beaudouin,et al.  Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. , 1996, Stroke.

[20]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[21]  A. Nunn,et al.  Nitroimidazoles and imaging hypoxia , 1995, European Journal of Nuclear Medicine.

[22]  Rudolf Graf,et al.  The ischemic penumbra , 1994, Current opinion in neurology.

[23]  V Beaudouin,et al.  Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion. A positron emission tomographic investigation in anesthetized baboons. , 1995, Stroke.

[24]  H J Tochon-Danguy,et al.  The fate of hypoxic tissue on 18F‐fluoromisonidazole positron emission tomography after ischemic stroke , 2000, Annals of neurology.

[25]  J. D. Chapman,et al.  Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. , 1983, Cancer research.

[26]  W D Heiss,et al.  Which targets are relevant for therapy of acute ischemic stroke? , 1999, Stroke.

[27]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.